Myriad Genetics, Inc. (MYGN): Price and Financial Metrics
Myriad Genetics, Inc. (MYGN)
Today's Latest Price: $11.58 USD
0.33 (2.93%)
Updated Jul 2 4:00pm
Add MYGN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
MYGN Stock Summary
- With a one year PEG ratio of 0.84, Myriad Genetics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 19.62% of US stocks.
- Over the past twelve months, MYGN has reported earnings growth of -680.94%, putting it ahead of only 2.84% of US stocks in our set.
- In terms of volatility of its share price, MYGN is more volatile than 79.98% of stocks we're observing.
- Stocks that are quantitatively similar to MYGN, based on their financial statements, market capitalization, and price volatility, are HBIO, KVHI, DSS, CCUR, and DHX.
- MYGN's SEC filings can be seen here. And to visit Myriad Genetics Inc's official web site, go to myriad.com.
MYGN Daily Price Range
MYGN 52-Week Price Range
MYGN Stock Price Chart Technical Analysis Charts
MYGN Price/Volume Stats
| Current price | $11.58 | 52-week high | $48.40 |
| Prev. close | $11.25 | 52-week low | $9.24 |
| Day low | $11.41 | Volume | 1,213,984 |
| Day high | $11.97 | Avg. volume | 1,185,895 |
| 50-day MA | $14.01 | Dividend yield | N/A |
| 200-day MA | $21.23 | Market Cap | 863.35M |
Myriad Genetics, Inc. (MYGN) Company Bio
Myriad Genetics discovers and commercializes molecular diagnostic tests that; determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties to improve patient care. The company was founded in 1991 and is based in Salt Lake City, Utah.
Loading social stream, please wait...